SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News

Last deal

$10M

Amount

Venture - Series Unknown

Stage

04.10.2023

Date

3

all rounds

$118M

Total amount

date founded

Financing round

General

About Company
SwanBio Therapeutics is a gene therapy company developing innovative treatments for neurological diseases.

Industry

Sector :

Subsector :

founded date

01.01.2017

founders

Number of employees

1-10

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

SwanBio Therapeutics, located in Boston and Philadelphia, specializes in genetically defined therapies for neurological disorders. The company's expertise in delivery and manufacturing enables it to bring its products to market. With a focus on a monogenic neurodegenerative condition affecting a rare population, SwanBio Therapeutics aims to deliver significant clinical efficacy. Founded in 2018, the company is driven by a passion for solving complex challenges and making meaningful discoveries through collaboration and compassion.
Contacts

location

Bala Cynwyd, PA, USA

Contact Email

Website URL

http://www.swanbiotx.com/

Social url

Similar Companies
1000
Voyager Therapeutics
Voyager TherapeuticsVoyager Therapeutics is a biotechnology company focused on developing gene therapies for neurological disorders.
Voyager Therapeutics

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company focused on developing gene therapies for neurological disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

total rounds

6

total raised

$374M
Tramontane Therapeutics
Tramontane TherapeuticsTramontane Therapeutics is a gene therapy company focused on developing treatments for prevalent metabolic and neurodegenerative diseases.
Tramontane Therapeutics

Tramontane Therapeutics

Tramontane Therapeutics is a gene therapy company focused on developing treatments for prevalent metabolic and neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics
Sio Gene Therapies
Sio Gene TherapiesSio Gene Therapies is a clinical-stage biopharmaceutical company focused on gene therapy for neurodegenerative diseases.
Sio Gene Therapies

Sio Gene Therapies

Sio Gene Therapies is a clinical-stage biopharmaceutical company focused on gene therapy for neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

3

total raised

$204.7M
Ziopharm oncology
Ziopharm oncologyZIOPHARM Oncology is a biotechnology company developing gene therapy, cell therapy, and cancer immunotherapy products.
Ziopharm oncology

Ziopharm oncology

ZIOPHARM Oncology is a biotechnology company developing gene therapy, cell therapy, and cancer immunotherapy products.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

9

total raised

$293.39M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$118M

Money Raised

Their latest funding was raised on 04.10.2023. Their latest investor Mass General Brigham Ventures. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
04.10.2023
Venture - Series Unknown
1
$10M
Syncona Partners LLP
Syncona Partners LLP
18.05.2022
Series B
2
$56M
Syncona Partners LLP
Syncona Partners LLP
Mass General Brigham Ventures
23.04.2020
Series A
2
$52M
—
Syncona Partners LLP

Syncona Partners LLP

Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Financial Services, Venture Capital

Location

London, UK

count Of Investments

41

count Of Exists

4
Syncona Partners LLP

Syncona Partners LLP

Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Financial Services, Venture Capital

Location

London, UK

count Of Investments

41

count Of Exists

4

Mass General Brigham Ventures

Mass General Brigham Ventures is a venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Finance, Financial Services

count Of Investments

24

count Of Exists

1
Co-Investors
Investors
3
1

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
Mass General Brigham Ventures
Yes
Series B
—
Syncona Partners LLP
Syncona Partners LLP
No
Seed
—
Partners Innovation Fund
Partners Innovation Fund
No
Series A
—

Mass General Brigham Ventures

Mass General Brigham Ventures is a venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Finance, Financial Services

count Of Investments

24

count Of Exists

1
Syncona Partners LLP

Syncona Partners LLP

Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Financial Services, Venture Capital

Location

London, UK

count Of Investments

41

count Of Exists

4
Partners Innovation Fund

Partners Innovation Fund

The Innovation Fund accelerates healthcare technology development and attracts external capital.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Boston, MA, USA

count Of Investments

33

count Of Exists

6

People

Founders
3
Florian Eichler
Florian Eichler

Florian Eichler

Florian Eichler is the Neurologist at Massachusetts General Hospital .

current job

Massachusetts General Hospital
Massachusetts General Hospital

organization founded

1
Florian Eichler

Florian Eichler

Rachel Salzman
Rachel Salzman

Rachel Salzman

current job

SwanBio Therapeutics
SwanBio Therapeutics

organization founded

1
Rachel Salzman

Rachel Salzman

Karen Kozarsky
Karen Kozarsky

Karen Kozarsky

Karen Kozarsky is the Founder & Chief Scientific Officer at SwanBio Therapeutics. She attended Massachusetts Institute of Technology.

current job

SwanBio Therapeutics
SwanBio Therapeutics

organization founded

1
Karen Kozarsky

Karen Kozarsky

Employee Profiles
10
Eileen Sawyer
Eileen Sawyer

Eileen Sawyer

Vice President Medical Affairs

Vice President Medical Affairs

Steven Zelenkofske

Steven Zelenkofske

Chief Medical Officer

Chief Medical Officer

Kumar Dhanasekharan
Kumar Dhanasekharan

Kumar Dhanasekharan

Vice President & Technical Operations

Vice President & Technical Operations

Jennifer Chen

Jennifer Chen

Cell culture scientist

Cell culture scientist

Adele Doyle

Adele Doyle

Executive assistant

Executive assistant

Wayne Froland

Wayne Froland

Chief technology and manufacturing officer

Chief technology and manufacturing officer

Karen Kozarsky
Karen Kozarsky

Karen Kozarsky

Co-Founder & Chief Scientific Officer

Co-Founder & Chief Scientific Officer

Rachel Salzman
Rachel Salzman

Rachel Salzman

Founder, President & CEO

Founder, President & CEO

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month